Terms: = Lymphoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
2484 results:
1. [Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt lymphoma RAJI Cell Line].
Li CT; Zhu XP; Wang SX; Peng QY; Zheng Y; Liu SQ; Lu XD; Wang YS; Weng D; Wang D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):476-482. PubMed ID: 38660855
[TBL] [Abstract] [Full Text] [Related]
2. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
3. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.
Lu Z; Lai Q; Li ZF; Zhong MY; Jiang YL; Feng LY; Zha J; Yao JW; Li Y; Deng XM; Xu B
Curr Med Sci; 2024 Apr; 44(2):298-308. PubMed ID: 38619682
[TBL] [Abstract] [Full Text] [Related]
4. Mutant FOXO1 controls an oncogenic network via enhancer accessibility.
Layden HM; Ellis JD; Bomber ML; Bartlett LN; Hiebert SW; Stengel KR
Cell Genom; 2024 Apr; 4(4):100537. PubMed ID: 38604128
[TBL] [Abstract] [Full Text] [Related]
5. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/akt signaling pathways].
Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
[TBL] [Abstract] [Full Text] [Related]
6. B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.
Gambino S; Quaglia FM; Galasso M; Cavallini C; Chignola R; Lovato O; Giacobazzi L; Caligola S; Adamo A; Putta S; Aparo A; Ferrarini I; Ugel S; Giugno R; Donadelli M; Dando I; Krampera M; Visco C; Scupoli MT
Sci Rep; 2024 Mar; 14(1):6595. PubMed ID: 38503806
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract] [Full Text] [Related]
8. Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis.
Vahabirad M; Daei S; Abbasalipourkabir R; Ziamajidi N
Biomed Res Int; 2024; 2024():7145339. PubMed ID: 38410788
[TBL] [Abstract] [Full Text] [Related]
9. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
[TBL] [Abstract] [Full Text] [Related]
10. [Effect of Chlorambucil Combined with Ibrutinib on Mantle Cell lymphoma Cell Line Jeko-1 and Its Related Mechanism].
Cai NN; Liu WY; Liu ZQ; Gong JH; Lin YL; Wang ZC; Huang YQ; Guo JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):132-137. PubMed ID: 38387911
[TBL] [Abstract] [Full Text] [Related]
11. Modulation of Apoptotic and akt/PI3K/mTOR pathways to target Glioblastoma Cells using synthetic compound PGEA-AN.
Saad S; Hanif F; Simjee SU; Faizi S; Khan L; Ashfaque A
J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S39-S46. PubMed ID: 38385470
[TBL] [Abstract] [Full Text] [Related]
12. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/akt/mTOR pathway.
Wu C; Chen S; Wu Z; Xue J; Zhang W; Wang S; Xindong Zhao ; Wu S
J Cancer Res Clin Oncol; 2024 Feb; 150(2):98. PubMed ID: 38381215
[TBL] [Abstract] [Full Text] [Related]
13. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.
Liu C; Zhao X; Wang Z; Zhang C; Zheng W; Zhu X; Zhang D; Gong T; Zhao H; Li F; Guan T; Guo X; Zhang H; Yu B
J Biol Chem; 2024 Mar; 300(3):105762. PubMed ID: 38367665
[TBL] [Abstract] [Full Text] [Related]
14. A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome.
Messana VG; Fascì A; Vitale N; Micillo M; Rovere M; Pesce NA; Martines C; Efremov DG; Vaisitti T; Deaglio S
Blood Adv; 2024 Apr; 8(8):1920-1933. PubMed ID: 38359376
[TBL] [Abstract] [Full Text] [Related]
15. Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
Liang X; Yu H; Liang R; Feng Z; Saidahmatov A; Sun C; Ren H; Wei X; Zhao J; Yang C; Liu H
J Med Chem; 2024 Feb; 67(4):2884-2906. PubMed ID: 38349664
[TBL] [Abstract] [Full Text] [Related]
16. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
Booth MR; Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
[TBL] [Abstract] [Full Text] [Related]
17. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
18. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/akt/mTOR pathway.
Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/akt pathway.
Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
[TBL] [Abstract] [Full Text] [Related]
[Next]
